StockMacro
Company, fund or insider

Help

Menu

David Arkowitz

Insider (Form 4 reporting owner): Director CIK 1296999Name as filed: Arkowitz DavidIts filings on EDGARAll insiders

Measures activity, not value. Not investment advice.

Since 30 Oct 2023, sold $10K in 2 sales (2 under a 10b5-1 plan set in advance) and bought $50K in 1 open-market purchase across 2 companies.

Companies

Role on the latest Form 4 for each; open-market trades counted
CompanyRoleTrades fromtoPurchasesSales
iBio IBIODirector10 Jan 202510 Jan 20251$50K–
Seres Therapeutics MCRBChief Financial Officer30 Oct 202316 Feb 2024–2$10K

What the share price did after their trades Share price return after each open-market trade, from the first close after the Form 4 became public, minus the return of the company's sector fund (the S&P 500 fund when the sector has none) over the same days. Median over the trades, in percentage points; at most one trade per company, side and month. It describes the past.

Median return minus the sector fund, in percentage points; "too few trades" under 5
Open-market tradesAfter 3 monthsAfter 6 monthsAfter 12 months
After purchasestoo few trades1 tradetoo few trades1 tradetoo few trades1 trade
After salestoo few trades2 tradestoo few trades2 tradestoo few trades2 trades

For a sale, a negative number means the shares did worse than the sector afterwards. It describes the past, not what comes next.

By year

Counted open-market trades, by trade date
YearPurchasesBoughtSalesSoldNet
20251$50K––$50K
2024––1$4K-$4K
2023––1$5K-$5K

Every trade

3, newest first; open-market purchases and sales only
Trade dateCompanySideSharesPriceValuePlanned Rule 10b5-1 plan: the insider set the trade up in advance, so its timing says less about their view. The box exists on Form 4 since April 2023. Filing
10 Jan 2025iBio IBIOBuy18,382$2.72$50KNoForm 4filed 13 Jan 2025
16 Feb 2024Seres Therapeutics MCRBSellafter exercising options3,939$1.08$4K10b5-1 planForm 4filed 16 Feb 2024
30 Oct 2023Seres Therapeutics MCRBSellafter exercising options4,066$1.35$5K10b5-1 planForm 4filed 31 Oct 2023

From Form 4: open-market purchases (code P) and sales (code S) only; awards, option exercises, tax withholding and gifts are not counted. Greyed rows are amended copies or another filer's report of the same trade and count nowhere. Measures activity, not value. Not investment advice.